DNA ploidy and cell cycle analysis in breast cancer.

During the past 10 years there has been considerable interest in the application of new technologies to identify human malignancy and predict disease outcome. Markers of cell proliferation and the technologies of flow cytometry and image analysis for the determination of DNA total content in human tumor cells have been studied in breast cancer for 20 years. In this review, the uses and limitations of these technologies for the determination of ploidy status are discussed. This review also considers the prognostic significance and potential clinical utility of ploidy measurements, S phase calculation, and individual cell cycle regulatory biomarker expression levels.

[1]  L. Case,et al.  The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients , 1990, Cancer.

[2]  D M Barnes,et al.  Demystified ... cell cycle. , 1998, Molecular pathology : MP.

[3]  E. Lees,et al.  Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.

[4]  T. Therneau,et al.  DNA content flow cytometry as a prognostic factor for node‐positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication , 1991, Cancer.

[5]  G. Auer,et al.  Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases , 1988, Cancer.

[6]  V. Gebski,et al.  The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. , 1999, Pathology.

[7]  J. Forteza,et al.  DNA ploidy and cytonuclear area of peritumoral and paratumoral samples of mastectomy specimens: a useful prognostic marker? , 2002, The European journal of surgery = Acta chirurgica.

[8]  J. Jett,et al.  MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY , 1974, The Journal of cell biology.

[9]  J. Soares,et al.  Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. , 1999, Journal of clinical pathology.

[10]  A. Harris,et al.  Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  J. Val-Bernal,et al.  MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors. , 2001, Histology and histopathology.

[12]  O. Kallioniemi,et al.  Evaluation of cell proliferation in breast carcinoma. Comparison of Ki‐67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count , 1990, Cancer.

[13]  J. Hudson,et al.  Application of flow cytometry to diagnostic pathology. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[14]  W. Lewis,et al.  Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer patients , 1990, Cancer.

[15]  C. Cohen,et al.  Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometric systems. , 1992, Analytical and quantitative cytology and histology.

[16]  H. Joensuu,et al.  Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer. , 1990, American journal of clinical pathology.

[17]  J. Coindre,et al.  Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[18]  Isabelle Bedrosian,et al.  Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.

[19]  S. Emdin,et al.  Mammographic growth rate, DNA ploidy, and S‐phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population , 1992, Cancer.

[20]  M. Stanley,et al.  Cytologic assessment of tumor cell kinetics: Applications of monoclonal antibody Ki‐67 to fine‐needle aspiration smears , 1991, Diagnostic cytopathology.

[21]  G. Clark,et al.  Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. , 2001, Cytometry.

[22]  K. Christov,et al.  DNA aneuploidy and cell proliferation in breast tumors , 1989, Cancer.

[23]  U. Göhring,et al.  p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer. , 2001, Journal of clinical pathology.

[24]  J Linder,et al.  Overview of digital imaging in pathology. The fifth wave. , 1990, American journal of clinical pathology.

[25]  R. Weinstein,et al.  Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  H. Joensuu,et al.  DNA index and S‐phase fraction and their combination as prognostic factors in operable ductal breast carcinoma , 1990, Cancer.

[27]  L. Brinton,et al.  Recent trends in breast cancer incidence and mortality , 2002, Environmental and molecular mutagenesis.

[28]  F. Krauer,et al.  The prognostic value of DNA ploidy and S—phase estimate in primary breast cancer: A prospective study , 1995, International journal of cancer.

[29]  G. Clark,et al.  Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients. , 2001, Clinical breast cancer.

[30]  S. Bosari,et al.  DNA flow cytometric analysis and prognosis of axillary lymph node‐negative breast carcinoma , 1992, Cancer.

[31]  G. Hortobagyi,et al.  Ki‐67 immunostaining in node‐negative stage I/II breast carcinoma. Significant correlation with prognosis , 1991, Cancer.

[32]  H. Frierson.  Ploidy Analysis and S‐Phase Fraction Determination by Flow Cytometry of Invasive Adenocarcinomas of the Breast , 1991, The American journal of surgical pathology.

[33]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[34]  C. Herman.  Cytometric DNA analysis in the management of cancer. Clinical and laboratory considerations , 1992, Cancer.

[35]  M. Bolla,et al.  S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  P. Steeg,et al.  Cyclins and breast cancer , 2004, Breast Cancer Research and Treatment.

[37]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[38]  A. Landay,et al.  Advances in flow cytometry for diagnostic pathology. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[39]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[40]  R. Bast,et al.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  K. Sasaki,et al.  Relationship between labeling indices of KI‐67 and brdurd in human malignant tumors , 1988, Cancer.

[42]  G. Pinkus,et al.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. , 1989, The American journal of pathology.

[43]  C Nicolini,et al.  A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry , 1982, Cell and tissue kinetics.

[44]  B. Czerniak,et al.  Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. , 1989, Human pathology.

[45]  J. Ross.  DNA Ploidy and Cell Cycle Analysis in Pathology , 1996 .

[46]  Prognostic Significance of the Combination of Biological Parameters in Breast Cancer , 2003, Surgery Today.

[47]  L. Koss,et al.  Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms. , 1991, Human pathology.

[48]  P H Bartels,et al.  Image analysis in quantitative cytopathology and histopathology. , 1989, Human pathology.

[49]  Y. Ko,et al.  Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status , 2001, Pathology international.

[50]  M. Merino,et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[51]  L. Norton,et al.  Focus on breast cancer. , 2002, Cancer cell.

[52]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[53]  Hideki Ninomiya.  Activities of , 2012 .

[54]  V. Chen,et al.  Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  D. Neuberg,et al.  Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score , 1993, Cancer.

[56]  J. Schulte‐Mönting,et al.  Ki‐67 immunostaining in human breast tumors and its relationship to prognosis , 1991, Cancer.

[57]  L. Kamentsky,et al.  Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry. , 1997, Archives of pathology & laboratory medicine.

[58]  S. Akashi-Tanaka,et al.  Prognostic and predictive factors in the adjuvant treatment of breast cancer , 2002, Breast cancer.

[59]  R. Weinberg,et al.  Functional genomics and the breast cancer problem. , 2002, Cancer cell.

[60]  T. Caspersson,et al.  DNA content and survival in mammary carcinoma. , 1980, Analytical and quantitative cytology.

[61]  J. Meyer,et al.  A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[62]  C. E. Gillett,et al.  The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. , 1995, British Journal of Cancer.

[63]  L. R. Gurley,et al.  An Improved Sum‐Of‐Normals Technique For Cell Cycle Distribution Analysis of Flow Cytometric Dna Histograms , 1981, Cell and tissue kinetics.

[64]  D. Karcher,et al.  DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[65]  L. Case,et al.  The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer , 1989, Cancer.

[66]  P. Diest,et al.  Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material: Correlations between flow cytometric, clinical, and pathologic variables , 1996 .

[67]  T. Bauer,et al.  DNA quantitation by image cytometry of touch preparations from fresh and frozen tissue. , 1990, American journal of clinical pathology.

[68]  T Koivula,et al.  Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S‐phase fraction: A proposed classification of DNA histograms in breast cancer , 1988, Cancer.

[69]  U. Moll,et al.  Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas. , 2001, International journal of oncology.

[70]  H. Peterse,et al.  p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up , 2000 .

[71]  C. Compton,et al.  College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. , 2000, Archives of pathology & laboratory medicine.

[72]  J. Meyer,et al.  Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. , 1980, Cancer research.

[73]  S. Ramaswamy,et al.  Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. , 2002, The Journal of clinical investigation.

[74]  N. Tanigawa,et al.  Expression of Cell-Cycle Regulator p27 Is Correlated to the Prognosis and ER Expression in Breast Carcinoma Patients , 2000, Oncology.

[75]  M. J. van de Vijver,et al.  Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial , 2000, Cancer.

[76]  Bartow Sa,et al.  DNA flow cytometry in solid tumors: practical aspects and clinical applications. , 1989 .

[77]  M. Cenci,et al.  DNA ploidy and TLI in association with other prognostic parameters in breast cancer. , 1999, Anticancer Research.

[78]  P. Lampertico,et al.  Proliferation index as a prognostic marker in breast cancer , 1993, Cancer.

[79]  E S Cibas,et al.  Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors. Comparison with flow cytometry and image analysis. , 1994, American journal of clinical pathology.

[80]  S. Wolman.  Fluorescence in situ hybridization: a new tool for the pathologist. , 1994, Human pathology.

[81]  A. Lee,et al.  DNA measurement by image analysis of paraffin-embedded breast carcinoma tissue. A comparative investigation. , 1991, American journal of clinical pathology.

[82]  H. Stein,et al.  Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. , 1986, Journal of immunological methods.

[83]  W H Schuette,et al.  A practical graphical method for estimating the fraction of cells in S in DNA histograms from clinical tumor samples containing aneuploid cell populations. , 1983, Cytometry.

[84]  I. Nath,et al.  The prognostic significance of ploidy analysis in operable breast cancer , 1991, Cancer.

[85]  J. Meyer,et al.  Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. , 1989, The American journal of pathology.

[86]  G. Clark,et al.  DNA and cell cycle analysis as prognostic indicators in breast tumors revisited. , 2001, Clinics in laboratory medicine.

[87]  M. Melamed,et al.  Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[88]  W. Sauerbrei,et al.  DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors. , 1995, Analytical and quantitative cytology and histology.

[89]  J. Peterse,et al.  Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[90]  S. Nordling,et al.  p27 Expression Correlates with Short-Term, but not with Long-Term Prognosis in Breast Cancer , 2001, Breast Cancer Research and Treatment.

[91]  J Azúa,et al.  Prognostic value from DNA quantification by static cytometry in breast cancer. , 1997, Analytical and quantitative cytology and histology.

[92]  W. McGuire,et al.  Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. , 1987, Cancer research.

[93]  H. Levin,et al.  A prospective comparison of DNA quantitation by image and flow cytometry. , 1990, American journal of clinical pathology.

[94]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[95]  C. Hitchcock.  Ki-67 staining as a means to simplify analysis of tumor cell proliferation. , 1991, American journal of clinical pathology.

[96]  T. Čufer,et al.  Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma. , 2001, Analytical and quantitative cytology and histology.

[97]  S. Tsutsui,et al.  Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer , 2001, International Journal of Clinical Oncology.

[98]  J. Burgos,et al.  S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers , 2005, Breast Cancer Research and Treatment.

[99]  J. Gerdes,et al.  New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[100]  G. Gasparini,et al.  Prognostic and predictive indicators in operable breast cancer. , 2003, Clinical breast cancer.

[101]  Shapiro Hm.  Flow cytometry of DNA content and other indicators of proliferative activity. , 1989 .

[102]  J. Bacus,et al.  The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. , 1988, American journal of clinical pathology.

[103]  Massimo Cristofanilli,et al.  Molecular prognostic factors for breast cancer metastasis and survival. , 2002, Seminars in radiation oncology.

[104]  J. Ross,et al.  DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. , 1996, Oncology.

[105]  I. Nenci,et al.  Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[106]  J. Soares,et al.  Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma , 2001, Journal of clinical pathology.

[107]  D. Schaid,et al.  DNA ploidy and the percentage of cells in S‐phase as prognostic factors for women with lymph node negative breast cancer , 1994, Cancer.

[108]  The clinical usefulness of chromosome analysis by flow cytometry. , 1989, Seminars in diagnostic pathology.

[109]  A. Brandes,et al.  Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression model. , 2001, Anticancer research.

[110]  R. Silvestrini,et al.  Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study. , 1997, Analytical and quantitative cytology and histology.

[111]  C. Redmond,et al.  DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S‐Phase fraction to outcome of patients in NSABP B‐04 , 1991, Cancer.

[112]  F. Sarkar,et al.  Genetic markers as prognostic indicators in breast cancer , 1992, Cancer.

[113]  Jenny C. Chang,et al.  Survival of patients with metastatic breast carcinoma , 2003, Cancer.

[114]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.